Management of benign prostatic hyperplasia

被引：0
|
作者：
Malbos, Damien [1 ]
机构：
[1] 24 Rue Pablo Picasso, F-15000 Aurillac, France
来源：
ACTUALITES PHARMACEUTIQUES | 2022年 / 61卷 / 618期
关键词：
5-alpha-reductase inhibitor; alpha-blocker; benign prostatic hypertrophy; prostate;
D O I：
10.1016/j.actpha.2022.07.013
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As they age, many men develop benign prostatic hyperplasia. Specialized and early treatment is essential to limit the functional repercussions and possible complications. The pharmacy team's expertise in lower urinary tract disorders contributes to optimal patient care. (C) 2022 Elsevier Masson SAS.All rights reserved
引用
收藏
页码：50 / 54
页数：5
相关论文
共 50 条
  • [21] Evaluation and medical management of benign prostatic hyperplasia
    Beckman, TJ
    Mynderse, LA
    MAYO CLINIC PROCEEDINGS, 2005, 80 (10) : 1356 - 1362
  • [22] Tailoring treatment in benign prostatic hyperplasia management
    de la Rosette, Jean J. M. C. H.
    CURRENT OPINION IN UROLOGY, 2009, 19 (01) : 1 - 2
  • [23] The role of naftopidil in the management of benign prostatic hyperplasia
    Hara, Noboru
    Mizusawa, Takaki
    Obara, Kenji
    Takahashi, Kota
    THERAPEUTIC ADVANCES IN UROLOGY, 2013, 5 (02) : 111 - 119
  • [24] Update on the medical management of benign prostatic hyperplasia
    Manoj Monga
    International Urology and Nephrology, 2002, 33 (1) : 67 - 68
  • [25] Patient Engagement in the Management of Benign Prostatic Hyperplasia
    Tenny R. Zhang
    Spyridon P. Basourakos
    Naeem Bhojani
    Kevin Zorn
    Dean Elterman
    Bilal Chughtai
    Current Bladder Dysfunction Reports, 2022, 17 : 125 - 130
  • [26] Facing the challenges of benign prostatic hyperplasia management
    de la Rosette, Jean
    CURRENT OPINION IN UROLOGY, 2008, 18 (01) : 9 - 10
  • [27] Personalized Medicine for the Management of Benign Prostatic Hyperplasia
    Bechis, Seth K.
    Otsetov, Alexander G.
    Ge, Rongbin
    Olumi, Aria F.
    JOURNAL OF UROLOGY, 2014, 192 (01): : 16 - 23
  • [28] Clinical features and management of benign prostatic hyperplasia
    Lane, T
    Shah, J
    HOSPITAL MEDICINE, 1999, 60 (10): : 705 - 709
  • [29] Advances in the medical management of benign prostatic hyperplasia
    Jewett, Michael A. S.
    Klotz, Laurence H.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (13) : 1850 - 1851
  • [30] Sexuality and management of benign prostatic hyperplasia with alfuzosin
    Leungwattanakij, S.
    Permpongkosol, S.
    Pripatnanont, C.
    Petchpaibul, T.
    Tongbai, T.
    Lojanapiwat, B.
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 : 427 - 427
12345